Inositol hexaphosphate inhibits proliferation and induces apoptosis of colon cancer cells by suppressing the AKT/mTOR signaling pathway

35Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

AKT, a serine/threonine protein kinase and mammalian target of rapamycin (mTOR) plays a critical role in the proliferation and resistance to apoptosis that are essential to the development and progression of colon cancer. Therefore, AKT/mTOR signaling pathway has been recognized as an attractive target for anticancer therapy. Inositol hexaphosphate (InsP6), a natural occurring phytochemical, has been shown to have both preventive and therapeutic effects against various cancers, however, its exact molecular mechanisms of action are not fully understood. The aim of the in vitro study was to investigate the anticancer activity of InsP6 on colon cancer with the focus on inhibiting the AKT1 kinase and p70S6K1 as mTOR effector, in relation to proliferation and apoptosis of cells. The colon cancer Caco-2 cells were cultured using standard techniques and exposed to InsP6 at different concentrations (1 mM, 2.5 mM and 5 mM). Cellular proliferative activity was monitored by 5-bromo-20-deoxyuridine (BrdU) incorporation into cellular DNA. Flow cytometric analysis was performed for cell cycle progression and apoptosis studies. Real-time RT-qPCR was used to validate mRNA levels of CDNK1A, CDNK1B, CASP3, CASP9, AKT1 and S6K1 genes. The concentration of p21 protein as well as the activities of caspase 3, AKT1 and p70S6K1 were determined by the ELISA method. The results revealed that IP6 inhibited proliferation and stimulated apoptosis of colon cancer cells. This effect was mediated by an increase in the expression of genes encoding p21, p27, caspase 3, caspase 9 as well a decrease in transcription of AKT1 and S6K1. InsP6 suppressed phosphorylation of AKT1 and p70S6K1, downstream effector of mTOR. Based on these studies it may be concluded that InsP6 can reduce proliferation and induce apoptosis through inhibition of the AKT/mTOR pathway and mTOR effector followed by modulation of the expression and activity of several key components of these pathways in colon cancer cells.

References Powered by Scopus

Global cancer statistics

31579Citations
N/AReaders
Get full text

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

23789Citations
N/AReaders
Get full text

Cancer statistics, 2016

23619Citations
N/AReaders
Get full text

Cited by Powered by Scopus

PI3K/ AKT/ mTOR pathway as a therapeutic target for colorectal cancer: A review of preclinical and clinical evidence

209Citations
N/AReaders
Get full text

Investigation of the medicinal significance of phytic acid as an indispensable anti-nutrient in diseases

64Citations
N/AReaders
Get full text

Pathogenesis and treatment of pancreatic cancer related pain

54Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kapral, M., Wawszczyk, J., Jesse, K., Paul-Samojedny, M., Kúsmierz, D., & Wȩglarz, L. (2017). Inositol hexaphosphate inhibits proliferation and induces apoptosis of colon cancer cells by suppressing the AKT/mTOR signaling pathway. Molecules, 22(10). https://doi.org/10.3390/molecules22101657

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

75%

Researcher 4

20%

Professor / Associate Prof. 1

5%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 6

40%

Agricultural and Biological Sciences 4

27%

Pharmacology, Toxicology and Pharmaceut... 3

20%

Chemistry 2

13%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 3

Save time finding and organizing research with Mendeley

Sign up for free